Move comes in the wake of repeated slamming by the SC and the Parliamentary committee on health and family welfare

The government is considering framing a separate policy for the approval of medicines, as well as clinical trials conducted in India - in a move that is expected to strengthen regulation on the pharmaceutical industry and ensure patient safety in the country. The Union Ministry of Health and Family Welfare has constituted a committee, headed by Ranjit Roy Chaudhury, advisor in the health ministry, to formulate a policy "for approval of new drugs, clinical trials and banning of drugs".